SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3qxm'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 10 ALA A 640
ASP A 641
ASP A 642
GLY A 726
PHE A 704
 None
None
None
None
NDZ  A 301 ( 4.9A)
 1.25A 1d4sA-3qxmA:
undetectable		 1d4sA-3qxmA:
17.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LBC_A_CYZA330_1
(GLUTAMINE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 12 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.80A 1lbcA-3qxmA:
37.5
1lbcC-3qxmA:
37.5		 1lbcA-3qxmA:
52.09
1lbcC-3qxmA:
52.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LBC_B_CYZB329_1
(GLUTAMINE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 9 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.96A 1lbcB-3qxmA:
37.3		 1lbcB-3qxmA:
52.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LBC_C_CYZC331_1
(GLUTAMINE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 12 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.91A 1lbcA-3qxmA:
37.4
1lbcC-3qxmA:
37.5		 1lbcA-3qxmA:
52.09
1lbcC-3qxmA:
52.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXE_A_1FLA2001_1
(SERUM ALBUMIN)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 11 LEU A 754
ILE A 751
VAL A 735
GLY A 734
LEU A 439
 None
 1.15A 2bxeA-3qxmA:
undetectable		 2bxeA-3qxmA:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXE_B_1FLB2001_1
(SERUM ALBUMIN)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 12 LEU A 754
ILE A 751
VAL A 735
GLY A 734
LEU A 439
 None
 1.16A 2bxeB-3qxmA:
undetectable		 2bxeB-3qxmA:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y05_A_RALA802_1
(PROSTAGLANDIN
REDUCTASE 1)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 VAL A 452
ARG A 450
GLY A 736
ASP A 497
 None
 0.78A 2y05A-3qxmA:
undetectable
2y05B-3qxmA:
undetectable		 2y05A-3qxmA:
20.63
2y05B-3qxmA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9R_A_ACTA700_0
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 6 GLY A 458
GLY A 657
MET A 660
ASN A 468
 None
NDZ  A 301 (-3.4A)
None
None
 1.01A 3e9rA-3qxmA:
undetectable		 3e9rA-3qxmA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9R_C_ACTC700_0
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 6 GLY A 458
GLY A 657
MET A 660
ASN A 468
 None
NDZ  A 301 (-3.4A)
None
None
 1.00A 3e9rC-3qxmA:
undetectable		 3e9rC-3qxmA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ERD_A_DESA600_1
(ESTROGEN RECEPTOR
ALPHA)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 12 LEU A 443
LEU A 435
LEU A 436
LEU A 481
LEU A 754
 None
 1.12A 3erdA-3qxmA:
undetectable		 3erdA-3qxmA:
23.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H6T_A_CYZA265_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 11 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.88A 3h6tA-3qxmA:
37.1
3h6tC-3qxmA:
37.0		 3h6tA-3qxmA:
52.09
3h6tC-3qxmA:
52.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H6T_B_CYZB265_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 9 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.82A 3h6tB-3qxmA:
37.0		 3h6tB-3qxmA:
52.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H6T_C_CYZC265_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 11 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.79A 3h6tA-3qxmA:
37.1
3h6tC-3qxmA:
37.1		 3h6tA-3qxmA:
52.09
3h6tC-3qxmA:
52.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ILT_B_TRUB800_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 12 LYS A 500
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.86A 3iltB-3qxmA:
34.8
3iltE-3qxmA:
34.8		 3iltB-3qxmA:
51.92
3iltE-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ILT_B_TRUB800_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 12 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
 None
 0.75A 3iltB-3qxmA:
34.8
3iltE-3qxmA:
34.8		 3iltB-3qxmA:
51.92
3iltE-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ILT_E_TRUE800_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 10 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.80A 3iltB-3qxmA:
34.8
3iltE-3qxmA:
34.8		 3iltB-3qxmA:
51.92
3iltE-3qxmA:
51.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JB2_A_SAMA1101_1
(STRUCTURAL PROTEIN
VP3)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		3 / 3 GLU A 429
ASP A 434
ASP A 426
 None
 0.75A 3jb2A-3qxmA:
undetectable		 3jb2A-3qxmA:
14.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LSF_H_PZIH800_0
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 8 TYR A 431
PRO A 501
MET A 503
LEU A 760
LYS A 764
 None
 0.36A 3lsfH-3qxmA:
37.1		 3lsfH-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LSL_A_PZIA800_0
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 TYR A 431
MET A 503
LEU A 760
LYS A 764
 None
 0.48A 3lslA-3qxmA:
13.3
3lslD-3qxmA:
37.1		 3lslA-3qxmA:
51.92
3lslD-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LSL_A_PZIA801_0
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 8 ILE A 488
PRO A 501
SER A 730
GLY A 732
 None
 0.26A 3lslA-3qxmA:
13.3
3lslD-3qxmA:
37.2		 3lslA-3qxmA:
51.92
3lslD-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LSL_D_PZID800_0
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 TYR A 431
MET A 503
LEU A 760
LYS A 764
 None
 0.48A 3lslA-3qxmA:
13.3
3lslD-3qxmA:
37.1		 3lslA-3qxmA:
51.92
3lslD-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LSL_D_PZID801_0
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 8 ILE A 488
PRO A 501
SER A 730
GLY A 732
 None
 0.28A 3lslA-3qxmA:
13.3
3lslD-3qxmA:
37.1		 3lslA-3qxmA:
51.92
3lslD-3qxmA:
51.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LSL_G_PZIG800_0
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 6 TYR A 431
MET A 503
LEU A 760
LYS A 764
 None
 0.39A 3lslG-3qxmA:
13.2		 3lslG-3qxmA:
51.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MEC_A_65BA561_0
(P66 REVERSE
TRANSCRIPTASE)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 12 LEU A 435
VAL A 735
GLY A 734
LEU A 760
TYR A 431
 None
 1.08A 3mecA-3qxmA:
undetectable		 3mecA-3qxmA:
18.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKD_A_CYZA266_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 9 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.79A 3tkdA-3qxmA:
37.5		 3tkdA-3qxmA:
52.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKD_A_CYZA266_2
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 5 ILE A 488
PRO A 501
LYS A 731
GLY A 732
 None
 0.28A 3tkdB-3qxmA:
37.7		 3tkdB-3qxmA:
52.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKD_B_CYZB267_1
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 5 ILE A 488
PRO A 501
LYS A 731
GLY A 732
 None
 0.28A 3tkdA-3qxmA:
37.4		 3tkdA-3qxmA:
52.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKD_B_CYZB267_2
(GLUTAMATE RECEPTOR 2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		6 / 9 LYS A 500
PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.78A 3tkdB-3qxmA:
37.7		 3tkdB-3qxmA:
52.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLB_A_TRPA901_0
(PROTEIN ARGONAUTE-2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		3 / 3 VAL A 735
ALA A 484
PHE A 502
 None
 0.91A 4olbA-3qxmA:
undetectable		 4olbA-3qxmA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5N_A_IPHA901_0
(PROTEIN ARGONAUTE-2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		3 / 3 VAL A 735
ALA A 484
PHE A 502
 None
 0.88A 4w5nA-3qxmA:
undetectable		 4w5nA-3qxmA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BS8_G_MFXG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ARG A 450
ASP A 476
ARG A 472
GLY A 469
 None
 0.82A 5bs8A-3qxmA:
undetectable
5bs8C-3qxmA:
undetectable
5bs8D-3qxmA:
undetectable		 5bs8A-3qxmA:
22.01
5bs8C-3qxmA:
22.01
5bs8D-3qxmA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BS8_H_MFXH101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ASP A 476
ARG A 472
GLY A 469
ARG A 450
 None
 0.85A 5bs8A-3qxmA:
undetectable
5bs8B-3qxmA:
undetectable
5bs8C-3qxmA:
undetectable		 5bs8A-3qxmA:
22.01
5bs8B-3qxmA:
25.25
5bs8C-3qxmA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTA_G_MFXG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ARG A 450
ASP A 476
ARG A 472
GLY A 469
 None
 0.80A 5btaA-3qxmA:
undetectable
5btaC-3qxmA:
undetectable
5btaD-3qxmA:
undetectable		 5btaA-3qxmA:
22.01
5btaC-3qxmA:
22.01
5btaD-3qxmA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_E_GFNE101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ASP A 476
ARG A 472
GLY A 469
ARG A 450
 None
 0.87A 5btdA-3qxmA:
undetectable
5btdB-3qxmA:
undetectable
5btdC-3qxmA:
undetectable		 5btdA-3qxmA:
22.01
5btdB-3qxmA:
25.25
5btdC-3qxmA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_G_GFNG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ARG A 450
ASP A 476
ARG A 472
GLY A 469
 None
 0.81A 5btdA-3qxmA:
undetectable
5btdC-3qxmA:
undetectable
5btdD-3qxmA:
undetectable		 5btdA-3qxmA:
22.01
5btdC-3qxmA:
22.01
5btdD-3qxmA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTF_F_GFNF101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ASP A 476
ARG A 472
GLY A 469
ARG A 450
 None
 0.85A 5btfA-3qxmA:
undetectable
5btfB-3qxmA:
undetectable
5btfC-3qxmA:
undetectable		 5btfA-3qxmA:
22.01
5btfB-3qxmA:
25.25
5btfC-3qxmA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTF_G_GFNG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ARG A 450
ASP A 476
ARG A 472
GLY A 469
 None
 0.80A 5btfA-3qxmA:
undetectable
5btfC-3qxmA:
undetectable
5btfD-3qxmA:
undetectable		 5btfA-3qxmA:
22.01
5btfC-3qxmA:
22.01
5btfD-3qxmA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTG_F_LFXF101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 7 ARG A 450
ASP A 476
ARG A 472
GLY A 469
 None
 0.86A 5btgA-3qxmA:
undetectable
5btgC-3qxmA:
undetectable
5btgD-3qxmA:
undetectable		 5btgA-3qxmA:
22.01
5btgC-3qxmA:
22.01
5btgD-3qxmA:
25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDQ_F_MFXF2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		4 / 6 ARG A 450
ASP A 476
ARG A 472
GLY A 469
 None
 1.05A 5cdqA-3qxmA:
undetectable
5cdqC-3qxmA:
undetectable
5cdqD-3qxmA:
undetectable		 5cdqA-3qxmA:
19.18
5cdqC-3qxmA:
19.18
5cdqD-3qxmA:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JS1_A_IPHA902_0
(PROTEIN ARGONAUTE-2)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		3 / 3 VAL A 735
ALA A 484
PHE A 502
 None
 0.91A 5js1A-3qxmA:
undetectable		 5js1A-3qxmA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TIX_B_OQRB302_0
(SULFOTRANSFERASE)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 10 ILE A 433
LEU A 439
VAL A 404
LEU A 402
SER A 440
 None
 1.47A 5tixB-3qxmA:
undetectable		 5tixB-3qxmA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DLZ_D_CYZD1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 11 PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.84A 6dlzA-3qxmA:
32.5
6dlzD-3qxmA:
31.9		 6dlzA-3qxmA:
16.86
6dlzD-3qxmA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DM1_D_CYZD1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)		 3qxm GLUTAMATE RECEPTOR
IONOTROPIC, KAINATE
2
(Homo
sapiens) 		5 / 11 PRO A 501
MET A 503
LEU A 752
LEU A 760
LYS A 764
 None
 0.84A 6dm1A-3qxmA:
32.5
6dm1D-3qxmA:
31.9		 6dm1A-3qxmA:
16.86
6dm1D-3qxmA:
16.86